These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5348442)

  • 1. Pharmacological studies of cinanserin in human isolated smooth muscle.
    Metcalfe HL; Turner P
    Br J Pharmacol; 1969 Oct; 37(2):519P-521P. PubMed ID: 5348442
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic interactions of methysergide and cinanserin on isolated human smooth muscle.
    Glegg AM; Turner P
    Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):301-9. PubMed ID: 5089219
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the effects of cinanserin and methysergide on responses of isolated human smooth muscle to acetylcholine.
    Metcalfe HL; Turner P
    Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):148-58. PubMed ID: 5437316
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Hydroxytryptamine antagonists related to cinanserin in human isolated smooth muscle.
    Kirby M
    J Pharm Pharmacol; 1972 Jan; 24(1):67-8. PubMed ID: 4401320
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of chlordiazepoxide, methysergide, and cinanserin as modifiers of punished behavior and as antagonists of N,N-dimethyltryptamine.
    Winter JC
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):147-59. PubMed ID: 5064096
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological studies on drugs affecting smooth muscle].
    Yanaura S; Suzuki M; Ishizaki M
    Nihon Yakurigaku Zasshi; 1968 Jul; 64(4):452-7. PubMed ID: 5751134
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of serotonin antagonists on bulbospinal systems.
    Proudfit HK; Anderson EG
    Brain Res; 1973 Oct; 61():331-41. PubMed ID: 4773165
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuation of conflict behavior with cinanserin, a serotonin antagonist: reversal of the effect with 5-hydroxytryptophan and alpha-methyltryptamine.
    Geller I; Hartmann RJ; Croy DJ; Haber B
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):165-74. PubMed ID: 4544101
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of serotonin antagonists with harmaline-induced changes in operant behavior and body temperature in the rat.
    Winter JC
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):120-32. PubMed ID: 5557389
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of 5-hydroxytryptamine antagonists and precursors on bulbospinal facilitation of spinal reflexes.
    Barasi S; Roberts MH
    Brain Res; 1973 Mar; 52():385-8. PubMed ID: 4700716
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
    Cheng HC; Long JP; Nichols DE; Barfknecht CF
    J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of cinanserin, a potent serotonin antagonist, on the acquisition of a running response in the rat.
    Rosen AJ; Cohen ME
    Neuropharmacology; 1973 Jun; 12(6):501-8. PubMed ID: 4725521
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of cinanserin (antiserotonin agent) on canine renal allografts.
    Murphy GP; Brede HD; Weber HW; Groenewald JH; Mirand EA
    J Surg Oncol; 1970; 2(2):145-54. PubMed ID: 4939050
    [No Abstract]   [Full Text] [Related]  

  • 14. Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses.
    Clineschmidt BV; Lotti VJ
    Br J Pharmacol; 1974 Feb; 50(2):311-3. PubMed ID: 4547673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism by methysergide and cinanserin of the antinociceptive action of morphine administered into the periaqueductal gray.
    Yaksh TL; DuChateau JC; Rudy TA
    Brain Res; 1976 Mar; 104(2):367-72. PubMed ID: 1260435
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive acitivity of 2'-(3-dimethylaminopropylthio)cinnamanilide (cinanserin) and related compounds. IV.
    Krapcho J; Millonig RC; Turk CF; Amrein BJ
    J Med Chem; 1969 Jan; 12(1):164-6. PubMed ID: 5763015
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural determinants of indole amine action on in vitro insulin release.
    Feldman JM; Lebovitz HE
    Endocrinology; 1972 Sep; 91(3):809-16. PubMed ID: 5041210
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for the functional interaction of two central neurotransmitters.
    Jacobs BL
    Psychopharmacologia; 1974; 39(1):81-6. PubMed ID: 4153732
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input.
    Haigler HJ; Aghajanian GK
    J Neural Transm; 1974; 35(4):157-273. PubMed ID: 4373531
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cinanserin, a serotonin antagonist on ethanol preference in the rat.
    Geller I; Hartmann RJ; Messiha FS
    Proc West Pharmacol Soc; 1975; 18():141-5. PubMed ID: 1178659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.